NASDAQ · Biotechnology
ZyVersa Therapeutics Inc. (ZVSA)
$0.00
0.00%
15
Oversold
Moving averages
SMA 200$0.18-99.44%
Company profile
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company is headquartered in Weston, Florida.
SectorHealthcare
IndustryBiotechnology
Market cap$1.54M
P/E ratioNone
EPS$-4.18
Beta0.791
Dividend yield0.00%
52-week high$0.80
52-week low$0.11
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
ARTL
Artelo Biosciences Inc
RSI 29
VRAX
Virax Biolabs Group Ltd - Class A
RSI 27
GOVX
Geovax Labs Inc
RSI 17
SKYE
Skye Bioscience Inc
RSI 31
IMNN
Imunon Inc
RSI 36
ACXP
Acurx Pharmaceuticals Inc
RSI 27
RSI alerts for ZVSA
An email when ZVSA closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 23 October 2026 at 1:03 AM EDT